General meeting

2023-07-05 Extraordinary General Meeting

The board of directors’ report

Auditor’s statement

2023-05-11 Annual General Meeting

The nomination committee´s proposal and motivated opinion for the Annual General Meeting 2023

Resolution on the introduction of a share-based incentive program for the members of the board of directors

Resolution on the introduction of a long-term incentive program for the companys senior management and key persons

The board of directors’ proposal to amend the Articles of Association

Remuneration report 2022

Auditor’s opinion the the remuneration to senior executives (swe)

Resolution on the introduction of a share-based incentive program for the members of the board of directors – Schedule A

Resolution on the introduction of a long-term incentive program for the companys senior management and key persons – Appendix A

Resolution on the introduction of a share-based incentive program for the members of the board of directors – Agreement

2022-05-11 - Annual General Meeting

The nomination committee´s proposal and motivated opinion for the Annual General Meeting 2022

Notification of attendance and form for advance voting

Remuneration report 2021

Auditor’s opinion on remuneration to senior executives (swe)

Auditor’s opinion on corporate governance report 2021 (swe)

2021-05-11 - Annual General Meeting

Notification of attendance and form for advance voting

The nomination committee´s proposal and motivated opinion for the Annual General Meeting 2021

Resolution on introduction of incentive program for certain board members

Resolution on introduction of incentive program for management and key persons

Proposal to amend the Articles of Association

Remuneration report 2020

Auditors opininion of corporate governance report 2020 (SWE)

Auditors opintion on remuneration to senior executives (SWE)

2021-03-05 Extraordinary General Meeting

Notification of participation and form for advance voting

Board of Directors report

Auditors statement

2020

2020-05-20

The nomination committee’s proposal and motived opinion for the annual general meeting 2020

Resolution on the introduction of a long-term performance-based incentive program for the new members of the Board of Directors

The Board of Directors proposal to amend the articles of association

The Board of Directors evaluation of remuneration to senior executives

The auditor’s opinion on remuneration to senior executives

2019

2019-05-15 - Annual General Meeting

The nomination committees proposal and motivated opinion

2019-01-07 - Extraordinary General Meeting

The Board’s proposal for amendment of the Articles of Association

The Board’s proposal for a decision on approval of a directed new share issue

The Board’s report

Auditor’s opinion (Swe)

2018

2018-08-13 - Extraordinary General Meeting

Notice of Extraordinary General Meeting

The Board’s proposal for a resolution in kind (Swe)

The Board’s proposal for a rights issue (Swe)

The Board’s proposal for an incentive program for senior executives and key employees (Swe)

The Board’s proposal for instruction to the Nomination Committee (Swe)

The Board’s proposal for a dividend of shares in I-Tech (Swe)

The Board’s proposal to amend the Articles of Association (Swe)

The main owners’ proposal for incentive programs for certain board members

Other proposals by major owners

The Board’s report in accordance with Chapter 13, Chapter 7, ABL

The Board’s report in accordance with Chapter 18, Section 6, ABL

The Board’s report according to Chapter 13, Section 6, ABL

New Articles of Association

Auditor’s opinion, Chapter 18, section 6

Auditor’s opinion, Chapter 13, section 6

Auditor’s opinion, Chapter 13, Section 8, paragraph

2018-06-13 - Annual General Meeting

Notice of Annual General Meeting

New Articles of Association (Swe)

The Board’s proposal for the issue of warrants (Swe)

2017

2017-05-10 - Annual General Meeting

Notice of Annual General Meeting (Swe)

The Board of Directors’ proposal for a new board (Swe)

The Board’s proposal for authorization (Swe)

2017-03-27 - Extraordinary General Meeting

Notice of Extraordinary General Meeting (Swe)

2016

27 April 2016 - Annual General Meeting

Notice of Extraordinary General Meeting (Swe)

2015

2015-09-28 - Extraordinary General Meeting

Notice Extraordinary Meeting (Swe)

2015-09-14 - Extraordinary General Meeting

Notice Extraordinary General Meeting (Swe)

2015-04-28 - Annual General Meeting

Minutes (Swe)
Notice of Annual General Meeting (Swe)

2014

2014-04-24 - Annual General Meeting

Notice of Annual General Meeting (Swe)

2013

2013-11-11 - Extraordinary General Meeting

2013-05-27 - Annual General Meeting

Notice of Annual General Meeting (Swe)

2012

2012-10-17 - Extraordinary General Meeting

2012-06-19 - Annual General Meeting

2011

2011-06-15 - Annual General Meeting

2010

2010-06-29 - Annual General Meeting

2009

2009-11-17 Extraordinary General Meeting

Vicorepharma

On vicorepharma.com, we use so-called cookies to analyze how our website is used in order to optimize and improve it. You choose yourself whether you want to consent to our use of cookies.

Vicorepharma is responsible for placing cookies on the website and for the processing of your personal data collected by them. For more information about our processing of your personal data, see our privacy policy

Cookie policy

Your consent applies to the following domain: vicorepharma.com
The cookie policy was last updated: 2023-06-29

Privacy Policy

Accept all Only necessary Settings

Show the cookies used on our website

Necessary cookies is needed in order for the website's basic functions to work correctly and for us to be able to save your choice of cookies.

cookies_set
Purpose: Saves the visitor’s choice of cookies.
Issued by: mk cookie master
Lifespan: 1 year

Domain: vicorepharma.com
selected_cookies
Purpose: Saves the visitor’s choice of cookies.
Issued by: mk cookie master
Lifespan: 1 year

Domain: vicorepharma.com

Statistical cookies helps the website owners to understand how visitors interact with the website by collecting and report this information.

_ga
Purpose: Used to understand how visitors’ navigate around the website.
Issued by: Google Analytics
Lifespan: 2 years

Domain: vicorepharma.com
_gat
Purpose: Used to throttle request rate. If Google Analytics is deployed via Google Tag Manager, this cookie will be named _dc_gtm_.
Issued by: Google Analytics
Lifespan: 1 minute

Domain: vicorepharma.com
_gid
Purpose: Used to understand how visitors’ navigate around the website.
Issued by: Google Analytics
Lifespan: 1 day

Domain: vicorepharma.com

What are cookies?

A cookie is a small text file that is placed on your device (computer/mobile/tablet that has access to the internet) by the website you visit – if you give your consent to this. The cookie can, for example, recognize you as a user when you visit our website and make it possible to remember important information that makes your visit more comfortable and provides an improved user experience. Cookies are so-called passive files that cannot spread dangerous software or viruses on your mobile device or computer.

There are two types of cookies, permanent cookies and session cookies. At vicorepharma.com we use both permanent cookies and session cookies. Permanent cookies are saved as a file on the computer for a certain time until the server that placed them, or you as a visitor choose to delete them. Session cookies are temporarily stored when you as a visitor are on the website and disappear when you close your browser.

Cookies can also be divided into first-party cookies and third-party cookies. First-party cookies are placed by the website you are visiting, while third-party cookies are placed by another website. At vicorepharma.com, we use both first-party cookies and third-party cookies.

How to avoid cookies

When you visit our website, you can refuse all or certain types of cookies. You can also withdraw or change your consent at any time by clicking here.

You can also block cookies by changing the settings in your browser. Then your browser will automatically refuse cookies or inform you when a website requests to store cookies.

After your visit, you can review and delete the permanent cookies that have been stored in your browser. In the list below, you will see the name of the cookies vicorepharma.com saves so that you can easily identify them.

Here you will find more information about how to manage cookies in your browser:

Chrome (https://support.google.com/accounts/answer/61416?co=GENIE.Platform%3DDesktop&hl=en)
Safari (https://support.apple.com/en-euro/guide/safari/sfri11471/mac)
Safari on iPhone and iPad (https://support.apple.com/en-euro/HT201265)
Internet Explorer and Microsoft Edge (https://support.microsoft.com/en-us/windows/delete-and-manage-cookies-168dab11-0753-043d-7c16-ede5947fc64d)
Firefox (https://support.mozilla.org/en-US/kb/cookies-information-websites-store-on-your-computer)
Opera (https://help.opera.com/en/latest/web-preferences/)

Cookies used by third parties

On vicorepharma.com there may be content that is embedded from YouTube. YouTube places cookies in your browser when you visit youtube.com or when you click on embedded content from YouTube on our website. vicorepharma cannot control these cookies or the personal data and information that may be collected. vicorepharma does not use the targeted marketing services offered by YouTube. As a user, you therefore need to check YouTube’s website for further information on how they manage cookies, what information they collect and how you can delete any third-party cookies.

Cookies used on vicorepharma.com

Necessary cookies is needed in order for the website's basic functions to work correctly and for us to be able to save your choice of cookies.

cookies_set
Purpose: Saves the visitor’s choice of cookies.
Issued by: mk cookie master
Lifespan: 1 year

Domain: vicorepharma.com
selected_cookies
Purpose: Saves the visitor’s choice of cookies.
Issued by: mk cookie master
Lifespan: 1 year

Domain: vicorepharma.com

Statistical cookies helps the website owners to understand how visitors interact with the website by collecting and report this information.

_ga
Purpose: Used to understand how visitors’ navigate around the website.
Issued by: Google Analytics
Lifespan: 2 years

Domain: vicorepharma.com
_gat
Purpose: Used to throttle request rate. If Google Analytics is deployed via Google Tag Manager, this cookie will be named _dc_gtm_.
Issued by: Google Analytics
Lifespan: 1 minute

Domain: vicorepharma.com
_gid
Purpose: Used to understand how visitors’ navigate around the website.
Issued by: Google Analytics
Lifespan: 1 day

Domain: vicorepharma.com

General

Vicore Pharma Holding AB (“Vicore”) shall only process personal data in accordance with applicable data protection law and high industry standards.

Personal data.

Vicore processes personal data provided to us;
(i) by you in the day-to-day communications, or

(ii) in connection with entering into or performing an agreement or business arrangement with you, or
(iii) by a third party allowed by law or your consent.

The personal data may consist of contact and identification details and other information relevant to the situation.

Purpose.

Vicore process personal data for the purpose of communicating with you and to perform, manage and comply with agreements between us as well as rights and obligations which are allowed by law or applicable regulation.

Legal grounds.

The legal grounds for processing personal data is either;
(i) your consent which shall be considered provided when you either voluntary submit the personal data or enter into an agreement with us, or
(ii) a legitimate interest allowed under law.

Security

Vicore shall use adequate technical and organisational security measures to protect the personal data from loss and to safeguard against access from unauthorised persons.

Transfers of personal data may only occur;
(i) to third parties who perform services on Vicore behalf and who may only process personal data in accordance with our instructions, and may not use personal data for their own purposes; and
(ii) outside the EU/EEA only in accordance with applicable data protection laws and subject to the EU Commission’s standard contractual clauses, and
(iii) as otherwise permitted by law or your consent.

Duration.

The duration we process personal data is limited to what is reasonable for the purpose of the processing, unless otherwise required or permitted by law.

Rights

Vicore is the controller of the personal data processing, meaning that we are responsible for that the personal data is processed correctly and in accordance with applicable data protection laws.

Unless prevented by applicable law, regulation or agreement data subjects have the right to;
(i) know what personal data we process about them,
(ii) request that we rectify or erase inaccurate or incomplete personal data
(iii) object to specific processing of personal data, and
(iv) receive the personal data provided by them and have the personal data transferred to another party responsible for data processing.

All communications with Vicore regarding how we process personal data or exercise of any of your rights can be sent by e-mail to info@vicorepharma.com or by post to the address above.

Reports and complaints can also be directed to Datainspektionen who is the supervisory authority for our processing of personal data.